x

Rechercher un essai clinique

* (*) Champ obligatoire

130 Résultat(s)

Trier par

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC =

Essai(s) clinique(s) national(aux)

ESPAGNE

Andalucía
SEVILLA

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-Metastatic Kidney Cancer (completed)
Hospital Universitario Virgen del Rocío
Unidad de Oncología Médica, Oncología Radioterápica y Radiofísica

ESPAGNE

Comunidad Valenciana
VALENCIA

ESPAGNE

Navarra
PAMPLONA

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors (Completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

FRANCE

AUVERGNE-RHONE-ALPES
LYON

FRANCE

OCCITANIE
TOULOUSE

ITALIE

CAMPANIA
NAPOLI

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial - QUASAR-2014-001
Azienda Ospedaliera Universitaria "Federico II"
Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica

ITALIE

LOMBARDIA
MILANO

Activity and Safety of Second Line SOrafenib After Pazopanib in Patients With Metastatic Renal Cell Carcinoma (SOAP Study)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. Oncologia medica genitourinaria

PAYS-BAS

Noord-Holland
AMSTERDAM

Increasing pazopanib exposure by splitting intake moments
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

BELGIQUE

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Essai en coursSTEP: Programme d'extension à long terme du Sorafénib - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Essai(s) clinique(s) multinational(aux)